Rajavithi Hospital is large public hospital located in Ratchathewi District, Bangkok, Thailand. It was founded in 1951 as the Women's Hospital, and is operated by the Ministry of Public Health's Department of Medical Services. With an inpatient capacity of 1,200 beds, it is one of the largest hospitals in Thailand.

There are 1,200 beds in Rajavithi Hospital; Ophthalmology Department.

During the past decade, Rajavithi Hospital; Ophthalmology Department conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Rajavithi Hospital; Ophthalmology Department" are "Diabetic Macular Edema" (2 trials). Many other conditions were trialed in "Rajavithi Hospital; Ophthalmology Department" in a lesser frequency.

Most popular intervention types in "Rajavithi Hospital; Ophthalmology Department" are "Drug" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (2 trials), "Sham Procedure" (2 trials) and "Aflibercept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rajavithi Hospital; Ophthalmology Department" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Rajavithi Hospital; Ophthalmology Department". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Rajavithi Hospital; Ophthalmology Department, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rajavithi Hospital; Ophthalmology Department, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".